Stock Price Quote

EPIGRAL LTD.

NSE : EPIGRALBSE : 543332ISIN CODE : INE071N01016Industry : ChemicalsHouse : Meghmani
BSE1343.10-0.85 (-0.06 %)
PREV CLOSE ( ) 1343.95
OPEN PRICE ( ) 1347.05
BID PRICE (QTY) 1342.60 (23)
OFFER PRICE (QTY) 1344.55 (1)
VOLUME 2512
TODAY'S LOW / HIGH ( )1330.95 1364.35
52 WK LOW / HIGH ( )870 1438.75
NSE1341.50-4.25 (-0.32 %)
PREV CLOSE( ) 1345.75
OPEN PRICE ( ) 1353.20
BID PRICE (QTY) 1340.10 (3)
OFFER PRICE (QTY) 1341.45 (1)
VOLUME 42861
TODAY'S LOW / HIGH( ) 1327.00 1360.95
52 WK LOW / HIGH ( )862.05 1443.25
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 11-08 2007
Management Info
Maulik Patel - Chairman Maulik Patel - Managing Director
Registered Office

Address Meghmani House,B/ H Safal Profitaire, Corporate Road,Nr. Auda Garden, Prahlad Nagar,
Ahmedabad,
Gujarat-380015

Phone 079-71761000 / 29709600

Email helpdesk@meghmanifinechem.com

Website www.meghmanifinechem.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

24Apr Epigral informs about analyst meet
Pursuant to Regulation 30 and Para (A) of Schedule III of SEBI (Listing..
22Apr Appointment of Company Secretary and
Appointment of Mr. Gaurang G. Trivedi (ACS 22307) as Company Secretary a..
03Apr Epigral commissions additional 45,000
Epigral has successfully commissioned of an additional 45,000 TPA (Tonne..
03Apr Epigral informs about press release
In continuation of letter dated 19.01.2023, wherein the Company had info..
02Mar Epigral informs about analyst meet
Pursuant to Regulation 30 and Para (A) of Schedule III of SEBI (Listing..

Financials

in Millions
QTR Mar 24 ANNUAL 24
Net Profit766.7000000000011957.89
Gross Profit 1128.52 2906.73
Operating Profit 1569.154877.26
Net Sales 5246.3319291.92

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Foseco India (BSE)
peergroup  3586.85 (4.96%)
M.Cap ( in Cr)2203.30
Neogen Chemicals (BSE)
peergroup  1548.50 (10.98%)
M.Cap ( in Cr)3906.07
Paushak (BSE)
peergroup  5160.00 (2.86%)
M.Cap ( in Cr)1587.91
Fine Organic Inds. (BSE)
peergroup  4562.15 (2.98%)
M.Cap ( in Cr)13913.19
Tanfac Industries (BSE)
peergroup  2320.00 (5.30%)
M.Cap ( in Cr)2315.45

Shareholding Pattern

PROMOTERS 71.49%
NON-INSTITUTION 27.1%
MUTUAL FUNDS/UTI 0.02%
GOVERNMENT 0.02%
FI/BANKS/INSURANCE 0%
FII 0%

About Epigral Ltd.

Epigral Ltd. was incorporated in the year 2007. Its today's share price is 1343.1. Its current market capitalisation stands at Rs 5632.33 Cr. In the latest quarter, company has reported Gross Sales of Rs. 23179.24 Cr and Total Income of Rs.21976.94 Cr. The company's management includes Gaurang Trivedi, Karana Patel, Raju Swamy, Kanubhai Patel, Sanjay Asher, Nirali Parikh, Manubhai Patel, Darshan Patel, Ankit Patel, Kaushal Ashishbhai Soparkar, Maulik Patel, Maulik Patel.

It is listed on the BSE with a BSE Code of 543332 , NSE with an NSE Symbol of EPIGRAL and ISIN of INE071N01016. It's Registered office is at Meghmani House,B/ H Safal Profitaire, Corporate Road,Nr. Auda Garden, Prahlad NagarAhmedabad-380015, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Khandwala & Khandwala, Patel & Khandwala, SRBC & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.